XVIII Farma-Biotech Cooperation Meeting
Last October 29th the employers’ organization of the pharmaceutical industry in Spain, Farmaindustria, organized its latest Farma-Biotech meeting to boost pre-clinical research. The event brings together representatives of national and international pharmaceutical companies with different Spanish biotechnology companies and research groups that have innovative clinical projects. Nanoligent and six other projects were hosted because according to […]
Oncology Innovation with Nanoligent
This past August Nanoligent was featured in the Spanish economy newspaper elEconomista. After a brief review on the importance of technology improvements for cancer treatment, Nanoligent technology is highlighted for its selectivity, efficiency, and low toxicity. As it is explained in the article, Nanoligent drug acts only on cancer cells, based on the specific interaction between […]
Nanoligent awarded 1st prize in ONCO Emergence Forum Barcelona 2018
The ONCO Emergence forum took place last June 21-22th at the Fira Gran Via (Barcelona). It is a networking conference focused on setting up transnational collaboration projects in the field of oncology and promotes interaction among research institutes, companies and medical facilities. Nanoligent was selected to present its innovative project in the Tech Transfer Competition, […]
Nanoligent featured in national press
This past September Nanoligent technology was featured in the health section of the Spanish national newspaper ABC. The capacity to selectivity kill metastatic stem cells, and thus, reduce the overall toxicity of the treatment is highlighted as the main strength of Nanoligent’s technology. There are currently no drugs on the market that selectively remove metastatic stem cells, […]
